Related Experiment Video
Updated: Oct 19, 2026

Assessment of Cardiac Morphological and Functional Changes in Mouse Model of Transverse Aortic Constriction by Echocardiographic Imaging
Published on: June 21, 2016
The relationship between electrocardiographic left ventricular hypertrophy criteria and echocardiographic mass in
Siri Sjöberg1, Frida Sundh2, Todd Schlegel3
1Department of Clinical Physiology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden; Duke University, Durham, NC, USA.
Insights
Electrocardiogram (ECG) criteria for left ventricular hypertrophy (LVH) are unreliable for assessing left ventricular mass (LVM) in transcatheter aortic valve replacement (TAVR) patients. QRS duration showed a moderate correlation with LVM.
Area of Science:
- Cardiology
- Medical Imaging
- Valvular Heart Disease
Background:
- Calcific aortic stenosis (AS) is a prevalent condition in the elderly, often leading to left ventricular hypertrophy (LVH) and heart failure symptoms.
- Transcatheter aortic valve replacement (TAVR) is a treatment for severe AS.
- Previous research indicates poor correlation between electrocardiogram (ECG) criteria for LVH and echocardiographic left ventricular mass (LVM), but this has not been studied in TAVR patients.
Purpose of the Study:
- To assess the diagnostic and quantitative accuracy of ECG LVH criteria for evaluating LVM in patients undergoing TAVR.
Main Methods:
- Twenty-four TAVR patients without pacemakers or bundle branch block underwent pre-procedural ECG and echocardiography.
- ECGs were analyzed using Sokolow-Lyon, Romhilt-Estes, and Cornell Voltage criteria for LVH, alongside spatial maximal QRS-T angle and 3D QRS maximal vector.
- Left ventricular mass (LVM) was quantified via echocardiography.
Main Results:
- 15 patients (63%) exhibited LVH by echocardiography.
- ECG criteria positivity rates were: Sokolow-Lyon (29%), Romhilt-Estes (21%), and Cornell Voltage (50%).
- No significant correlation was found between LVM and conventional ECG LVH criteria or spatial parameters. QRS duration demonstrated a moderate correlation with LVM (r=0.56, p=0.005).
Conclusions:
- Conventional ECG criteria for LVH are not recommended for LVM evaluation in TAVR patients.
- QRS duration is the most useful ECG parameter, showing a moderate correlation with LVM in this cohort.
Introduction:
Calcific aortic stenosis (AS) is a common valvular disease among the elderly. Often, AS leads to left ventricular hypertrophy (LVH) and symptoms of heart failure. Severe AS can be treated by transcatheter aortic valve replacement (TAVR). Previous studies have shown that electrocardiogram (ECG) criteria for LVH correlate poorly with left ventricular mass (LVM) in echocardiography. However, such correlations have not been studied in TAVR patients.
Aims:
To evaluate ECG LVH criteria as a method of diagnosing and quantifying LVH in patients with AS undergoing TAVR.
Material And Methods:
Twenty-four patients, with neither pacemaker nor bundle branch block, who had undergone pre-TAVR ECG and echocardiography were included. The ECGs were evaluated using the Sokolow-Lyon, Romhilt-Estes and Cornell Voltage criteria for LVH as well as spatial maximal QRS-T angle and 3D QRS maximal spatial vector. The LVM was measured by echocardiography.
Results:
15 (63%) patients met the echocardiographic threshold for LVH. 7 patients (29%) were positive by the Sokolow-Lyon, 5 (21%) by the Romhilt-Estes and 12 (50%) by the Cornell Voltage criteria for LVH. There was no correlation between LVM and conventional ECG LVH criteria or spatial parameters. QRS duration correlated with LVM (r=0.56, R(2)=0.31, p=0.005). However, there was no correlation between QRS duration and LVM index or relative wall thickness (RWT).
Conclusions:
In TAVR patients, none of the ECG LVH criteria should be used for evaluation of LVM. QRS duration is moderately correlated to LVM and is the most useful ECG estimate of LVM.
More Related Videos
Related Concept Videos
Cardiac Catheterization III: Left Heart Catheterization
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy

